Fig. 2From: The added value of musculoskeletal ultrasound to clinical evaluation in the treatment decision of rheumatoid arthritis outpatients: physician experience mattersComparison of the percentage of SR and TR that considered GUS-7, DMARD related AE, DMARD costs/availability and DMARD maximum doses as determinant in the treatment proposalBack to article page